Page 29 - ebook HCC
P. 29



26 PROGRAMME AND ABSTRACTS GENEVA, SWITZERLAND EASL HCC SUMMIT 27
FEBRUARY 13 - 16, 2014










# Title Last name First Name # Title Last name First Name

IMMUNOHISTOCHEMICAL FEATURES OF PI3K/AKT PATHWAY ACTIVATION BY HCV AND
B32 Dhanasekaran Renumathy B42 Lerat Herve
HEPATIC ADENOMAS IN MEN ITS ROLE IN LIVER CARCINOGENESIS
IMPACT OF GLUTATHIONE PEROXIDASE 4 MICRORNA-125B MODULATES CELL GROWTH,
OVEREXPRESSION ON HEPATOCELLULAR B43 METABOLISM AND HBV REPLICATION VIA Deng Wanyu
B33 Rohr-Udilova Nataliya
CARCINOMA: AN IN VITRO AND IN VIVO LIN28B/LET7 AXIS
STUDY
POSTER BOARDS B34 SOLUBLE MIC PROTEINS IN HEPATITIS Tong Hoang Van B44 ANALYSIS OF DLC 1 GENE POLYMORPHISM Vellingiri Balachandar POSTER BOARDS
AMONG HEPATOCELLULAR CARCINOMA
PATIENTS IN INDIA
B VIRUS INDUCED HEPATOCELLULAR
CARCINOMA
MUTATIONS IN TP53, CTNNB1 AND PIK3CA
GLUTAMINE PROTECTS AGAINST BETA- B45 GENES IN HEPATOCELLULAR CARCINOMA Buonaguro Franco M.
B35 CATENIN-DEPENDENT TUMOR DEVELOPMENT Godard Cécile ASSOCIATED WITH HEPATITIS B AND
IN LIVER HEPATITIS C VIRUS INFECTIONS

MITOTIC KINESIN-LIKE PROTEIN 2 LONGITUDINAL MRI-BASED RESPONSE
B36 DEREGULATION IN HEPATOCELLULAR Bourgain Florence MONITORING OF SORAFENIB TREATMENT
CARCINOMA B46 IN TRANSPLANTED VERSUS CHEMICALLY Gross Claudia M.
INDUCED RAT HCC
MICRORNA EXPRESSION PATTERN IN
B37 PBMCS FROM PATIENTS WITH HCV-RELATED Piluso Alessia SURFACE MARKER PROFILING OF HUMAN
MALIGNANCIES HEPATOCELLULAR CARCINOMA CELLS USING
B47 Ghanekar Anand
HIGH THROUGHPUT FLOW CYTOMETRY
EXPRESSION OF TH1/TH2 CYTOKINES IN SCREENING
HEPATITIS B MEDIATED HEPATOCELLULAR
B38 Deka Manab
CARCINOMA IN PATIENTS FROM NORTH EAST THE CROSS TALK BETWEEN HEPATIC
INDIA STELLATE CELLS AND HCC CELLS OFFSETTS
B48 Giannelli Gianluigi
SORAFENIB EFFECTIVENESS VIA LAMININ-5
B39 STUDY OF HNF4ALFA ROLE IN MOUSE LIVER Sartor Chiara INTEGRINS ENGAGEMENT
THE ROLE OF GROWTH HORMONE RECEPTOR
B40 Stiedl Patricia
IN LIVER FIBROSIS AND CANCER
CELL CYCLE DEREGULATION BY HCV
B41 PROTEIN EXPRESSION, A POTENTIAL Florimond Alexandre
HEPATOCARCINOGENIC TRIGGER
   24   25   26   27   28   29   30   31   32   33   34